Fredun Pharmaceuticals Limited

FREDUN.BO·BSE·Healthcare
Compare
1,391.20+19.70 (+1.44%)today
At close: Oct 22, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,371.50
Open1,354.90
Day range1,354.901,403.65
52-week range454.051,666.35
Off day high−0.89%
Off 52-week high−16.51%
Volume12.31K
Avg. volume (3M)26.89K
Market cap23.76B
EPS (TTM)27.53
Forward P/E—
P/E ratio (TTM)50.53
Dividend yield0.02% (0.2300)
Beta (5Y)0.86
Shares outstanding17.08M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target—
Profit margin5.24%

Against its peers

Compare in full ›
FREDUN.BO SOLARA.NS INDSWFTLAB.BO MOREPENLAB.NS 000513.SZ RPGLIFE.NS
Market cap 23.76B 29.87B 30.59B 64.48B 23.10B 45.98B
P/E (TTM) 50.5 80.3 51.7 46.0 13.8 38.4
Forward P/E — 19.7 — — 10.4 29.5
Price/book 8.2 2.1 2.1 5.3 1.7 7.6
Dividend yield 0.02% — — 0.17% 9.09% 0.86%
1-year change +156.74% +8.95% +233.58% +135.36% −27.62% +19.28%
Today +1.44% −4.50% +1.15% +1.95% −3.49% −0.61%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Univest·

Beta Drugs vs Dishman Carbogen Amcis vs Fredun Pharmaceuticals

Beta Drugs PE 45.47, mkt cap Rs 2,104 crore. Dishman Carbogen Amcis PE 142.48, mkt cap Rs 2,301 crore. Fredun Pharmaceuticals PE 57.90, mkt cap Rs 2,537 crore. Beta Drugs vs Dishman Carbogen Amcis vs Fredun Pharmaceuticals starts with the…

From articles in the 4Search news index.

In the news

9mentions in 30 days
9with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.